Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 62Head & Neck 2Gynecologic 2Thoracic 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 25Colorectal Neoplasms 21Lung Neoplasms 12Neoplasms 7Pancreatic Neoplasms 6Ovarian Neoplasms 6Head and Neck Neoplasms 6Colonic Neoplasms 6Stomach Neoplasms 5Esophageal Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Small Cell Lung Carcinoma 4Rectal Neoplasms 4Neoplasm Metastasis 4Triple Negative Breast Neoplasms 3Peritoneal Neoplasms 3Mesothelioma 3Melanoma 3Carcinoma, Pancreatic Ductal 3Breast Neoplasms 3Urinary Bladder Neoplasms 2Thyroid Neoplasms 2Kidney Neoplasms 2Fallopian Tube Neoplasms 2Carcinoma, Renal Cell 2Biliary Tract Neoplasms 2Vipoma 1Uterine Cervical Neoplasms 1Tracheal Neoplasms 1Spinocerebellar Degenerations 1

Interventions

pembrolizumab 9Nivolumab 4Carboplatin 4spartalizumab 2durvalumab 2Paclitaxel 2Immunohistochemistry 2Gemcitabine 2Cisplatin 2Bevacizumab 2130-nm albumin-bound paclitaxel 2tremelimumab 1ribociclib 1regorafenib 1obinutuzumab 1naptumomab estafenatox 1liposomal doxorubicin 1enzalutamide 1atezolizumab 1aflibercept 1abiraterone 1SGN-LIV1A 1Ritonavir 1Remote Patient Monitoring 1Polymerase Chain Reaction 1Oxaliplatin 1NEO212 1Mass Spectrometry 1Lopinavir 1Leucovorin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esophageal Squamous Cell Carcinoma × Fluorouracil × Thoracic × Clear all
NCT02658214 2020-08-20

Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors

AstraZeneca

Phase 1 Completed
32 enrolled
BreastGastrointestinalGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms, Carcinoma, Pancreatic Ductal, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡